MEDPATH-2020 · Alexion is a global biopharmaceutical company focused on serving patients and...
Transcript of MEDPATH-2020 · Alexion is a global biopharmaceutical company focused on serving patients and...
UNITED Scientific Group
A non-profit organization
Exhibitor
MED
PATH
-202
0FI
RST E
DITIO
N MEDICAL PATHOLOGY
FEBRUARY17-19, 2020
DoubleTree by Hilton Houston Intercontinental Airport
15747 John F. Kennedy Blvd.Houston, TX 77032 USA
The event invitation code is: Medpath
We are excited to use Whova as our event platform. Attendees please download Whova event app.
Alexion is a global biopharmaceutical company focused on serving patients and families affected by rare diseases through the discovery, development and commercialization of life-changing therapies.
Breakthrough Therapies
Through the transformative power of our science, Alexion has delivered life-changing ther-apies to patients suffering from rare diseases. We have pioneered the complex field of complement biology and delivered solutions to challenges that once seemed impossible for patients living with rare and devastating diseases.
Alexion has developed and delivered therapies for the treatment of complement-mediated diseases – two for patients with paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS), and one for patients with anti-aquaporin-4 (AQP4) an-tibody positive neuromyelitis optica spectrum disorder (NMOSD) and anti-acetylcholine receptor (AchR) antibody-positive generalized myasthenia gravis (gMG).
Alexion also has two highly innovative enzyme replacement therapies for patients with life-threatening and ultra-rare metabolic disorders—hypophosphatasia (HPP) and lysosom-al acid lipase deficiency (LAL-D).
07:50-08:00 Introduction to MedPath-2020 @ Seattle I
Keynote Session @ Seattle I
08:00-08:30 Andy N.D. Nguyen, University of Texas-Houston, Houston, TX The Coming Digital Pathology Revolution: Diagnostic Systems for Whole Slide Imaging
08:30-09:00 Carl Morrison, Roswell Park Comprehensive Cancer Center, Buffalo, NY Pathologists as Gatekeepers to Precision Medicine
09:00-09:30 Robert E. Brown, UTHealth McGovern Medical School, Houston, TX M2 Macrophages in Crystal Storing Histiocytosis Associated with Plasma Cell Myeloma
09:30-10:00 Agnieszka Wiktiewicz, Roswell Park Comprehensive Cancer Center, Buffalo, NY Precision Medicine in Pancreatic Cancer: The Importance of Orthogonal Approaches to Target A
Therapy Recalcitrant Diseases
10:00 -10:20 Coffee Break @ Prefunction Foyer
Session-I @ Seattle I
Hematopathology | Laboratory Medicine
Chairs: Morayma Reyes Gil, Montefiore Medical Center, Bronx, NY Eleanor M. Travers, Private Medical Practice, Philadelphia, PA
10:20-10:40 Morayma Reyes Gil, Montefiore Medical Center, Bronx, NY Artificial Intelligence to Identify Neutrophil Extracellular Traps in Peripheral Blood Smears
10:40-11:00 Jie-Gen Jiang, Rutgers New Jersey Medical School, Newark, NJ Plasma Cell Myeloma with Dual Expression of Kappa and Lambda Light Chains
11:00-11:20 Wei Cui, The University of Kansas Medical Center, Kansan City, KS p53 Expression in Large B-cell Lymphomas with MYC Extra Copies and CD99 Expression in Large
B-cell Lymphomas in Relation to MYC Status
11:20-11:40 Ling Guo, Ohio State University Wexner Medical Center, Columbus, OH Ultrasensitive Automated RNA in situ Hybridization for Kappa and Lambda Light Chain mRNA
Detects B-cell Clonality in Tissue Biopsies with Performance Comparable or Superior to Flow Cytometry
11:40-12:00 Katsiaryna Laziuk, University of Missouri School of Medicine, Columbia, MO T -cell Lymphoma/Leukemias: The Uncommon & Rare
12:00-12:20 Yaseen Mohiuddin, University of Michigan Medical School, Ann Arbor, MI An Uncommon Presentation of Diffuse Large B-cell Lymphoma as a Pleural Based Cavitary Lesion
12:20-12:40 Beata Grygalewicz, Maria Sklodowska-Curie Institute Oncology Center, Poland Is the Duplication and Deletion of 11q a Specific Change only for Burkitt-like Lymphoma with 11q
Aberrations?
DaY...One Feb 17Monday
Med
pat
h-20
20 P
rog
ram
07:30-07:50 Registrations & Badge Pick-up @ Prefunction Foyer
12:40-13:00 Michelle Lin, Houston Methodist Hospital, Houston, TX Mullerian-Type Clear Cell Carcinoma of the Testis: An Extremely Rare Occurrence with Unique
Clinical Presentation
13:00-13:20 Lei Chen, The University of Texas Health Science Center McGovern Medical School, Houston, TX Acute Leukemia of Ambiguous Lineage Presents with Pelvic Mass and Retroperitoneal
Lymphadenopathy
13:20-14:00 Lunch Break @ Dallas/Houston
14:00-14:20 C. Cameron Yin, University of Texas MD Anderson Cancer Center, Houston, TX Clinical Applications of Next-generation Sequencing in the Diagnosis, Risk Stratification and
Target Therapy of Myeloid Neoplasms
14:20-14:40 Jie Xu, MD Anderson Cancer Center, Houston, TX Lymphomas Being Potential Candidates for PD-1 Blockade Immunotherapy
14:40-15:00 Min Shi, Mayo Clinic, Rochester, MN Mixed-Phenotype Large Granular Lymphocytic Leukemia: A Rare Subtype in the Large Granular
Lymphocytic Leukemia Spectrum
15:00-15:20 Ji Yuan, University of Nebraska Medical Center, Omaha, NE Application of Flow Cytometry in Diagnosis of Chronic Myelomonocytic Leukemia
15:20-15:40 Eleanor M. Travers, Private Medical Practice, Philadelphia, PA Prescriptive Visual Informatics Reporting of Early Scientific “Trigger Signals” with a Diagnostic
Critical Path (DCP) API to Avert Adverse Diagnostic Events in High Risk Patients
15:40-16:00 Katell Peoc’h, University of Paris, France Clinical Biomarkers of Acute Mesenteric Ischemia: First Results from the SURVIBIO Trial
16:00-16:20 Coffee Break @ Prefunction Foyer
16:20- 16:40 Alden E Chesney, VCU Medical Center, Richmond, VA Interference of Daratumumab with Flow Cytometric Assessment of Plasma Cell Myeloma
16:40-17:00 Weijie Li, UMKC School of Medicine, Kansas, MO Flow Cytometry Detection of Normal/ Reactive Minor Cell Populations in Peripheral Blood and
Bone Marrow: Phenotypic Features and Clinical Significance
17:00-17:20 Lisa Maness, Winston-Salem State University, Winston-Salem, NC The Inhibitory Effect of Essential Oils on Rhizopus stolonifer, Trichophyton mentagrophytes, and
Microsporum gypseum
17:20-17:40 Lian-Wang Guo, The Ohio State University, Columbus, OH Nullifying Epigenetic Writer DOT1L Attenuates Intimal Hyperplasia
17:40-18:00 Shinya Tajima, St. Marianna University School of Medicine, Japan Nuclear Inverse Polarity Papillary Lesions with Lack of Myoepithelial Cells: A Report of the Two
Cases
Med
pat
h-20
20 P
rog
ram
Session-II @ Seattle I
Anatomical | Neuro | Surgical | Diagnostic | Toxicologic
Chairs: Thomas Weber, University of Hamburg, Germany Larry Nichols, Mercer University School of Medicine, Macon, GA
08:00-08:20 Kanwaljit Aulakh, Pathology Laboratory Associates, Tulsa, OK Data Warehouse Strategies and the Modern Anatomic Pathology Laboratory: Quality
Management, Patient Safety, and Pathology Productivity Issues and Opportunities
08:20-08:40 Larry Nichols, Mercer University School of Medicine, Macon, GA Must Anatomic Pathologists Surrender the Diagnosis of Fungal Hyphae to the Microbiology
Laboratory?
08:40-09:00 Charles M Lombard, El Camino Hospital, Los Altos Hills, CA The Pathogenesis of Pulmonary Lymphangioleiomyomatosis
09:00-09:20 Louis Maximilian Buja, UTHealth McGovern Medical School, Houston, TX Diagnostic Surgical Pathology of Aortic Diseases
09:20-09:40 Karla Lais Pegas, Santa Casa de Misericordia Hospital, Brazil Cancer: What if it were an Infectious Disease?
09:40-10:00 Steven J Soldin, NIH, Bethesda, MD The Role of Mass Spectrometry in Optimizing the Diagnosis and Treatment of Thyroid Disease
10:00-10:20 Coffee Break @ Prefunction Foyer
10:20-10:40 Thomas Weber, University of Hamburg, Germany Laboratory Diagnostics in Dementia
10:40-11:00 Maria Del Carmen Dominguez Grandal, University Hospital Complex of Vigo, Spain Cystinuria: The Importance of Sediment
11:00-11:20 Michael Punsoni, University of Nebraska Medical Center, Omaha, NE Diagnostic Criteria of Diffuse Gliomas and Implications for Management
11:20-11:40 Edwin Roger Parra Cuentas, The University of Texas MD Anderson Cancer Center, Houston, TX Cancer Immunoprofiling Using Multiplexed Platforms and Biomarker Discovery
11:40-12:00 Agata Zieba-Wicher, Navinci Diagnostics, Sweden The Next Generation in situ Staining for Improved Protein Detection
12:00-12:20 Wenbin Tan, University of South Carolina School of Medicine, Columbia, SC Molecular Pathogenesis of Port Wine Stain Blood Vessels
12:20-12:40 Maram Abdaljaleel, University of Jordan, Jordan CD34 Immunostain Increases the Sensitivity of Fetal Vascular Malperfusion Diagnosis in Placentas
of Stillbirths
12:40-13:00 Neda Zarrin-Khameh, Baylor College of Medicine, Houston, TX Fine Needle Aspiration of Alveolar Soft Part Sarcoma
DaY...Two Feb 18Tuesday
Med
pat
h-20
20 P
rog
ram
13:00-14:00 Lunch Break @ Dallas/Houston
14:00-14:20 Donghwa Baek, Houston Methodist Hospital, Houston, TX Monophasic Epithelial Synovial Sarcoma Initially Diagnosed as Metastatic Adenocarcinoma of
Unknown Primary
14:20-14:40 Daniel O’Conor, Baylor College of Medicine, Houston, TX Musculoskeletal Injuries in Spaceflight
14:40-15:00 Vasanthi Mowat, Covance CRS Ltd, UK Interpreting Adversity of Histopathological Findings in Safety Assessment Studies
15:00-15:20 Shunhua Guo, Indiana University School of Medicine, Indianapolis, IN Vasculitis Manifested as Multiple Mass Lesions
15:20-15:40 Erika Resetkova, UT MD Anderson Cancer Center, Houston, TX Diagnosis, Classification and Current Therapeutic Approaches to High Risk Lesions of the Breast
in the UT MD Anderson Cancer Center
15:40-16:00 Coffee Break @ Prefunction Foyer
16:00-16:20 Marja Nevalainen, Medical College of Wisconsin, Wauwatosa, WI Positive STAT5 Protein and Locus Amplification Status Predicts Recurrence after Radical
Prostatectomy to Assist Clinical Precision Management of Prostate Cancer
16:20-16:40 Carlos P. Sosa, Mayo Clinic, Eagan, MN mRNA Expression-Based and Novel Fusions Detection in Genitourinary Cancers: Prognosis and
Discovery
16:40-17:00 Adam L. Booth, University of Texas Medical Branch, Galveston, TX Implementation of a Novel Patient-Pathologist Consultation Program and Survey of Patient
Experience
17:00-17:20 Ke (Corey) Xu, St. Jude Children’s Research Hospital, Memphis, TN Structure and Evolution of Double Minutes in Diagnosis and Relapse Brain Tumors
Med
pat
h-20
20 P
rog
ram
Med
pat
h-20
20 P
rog
ram
17:20-18:00 Poster Session @ Prefunction Foyer
P-01 Andrew Rostron, Public Health England, UK Newborn Outcome System (NBO) – Public Health England
P-02 Ding Dai, Virginia Commonwealth University School of Medicine, Richmond, VA A Unique Case Report of Rectal Prolapse as an Initial Manifestation of Malignant Peritoneal Epithelioid
Mesothelioma
P-03 Eduardo Cambruzzi, Santa Casa de Misericordia Hospital, Brazil Silent Corticotroph Pituitary Adenoma: Clinical Course and Histological Findings
P-04 Guangjing Zhu, University of Maryland, Baltimore, MD Hepatocellular Neoplasm in Transplanted Liver: New Versus Recurrent?
P-05 Dietmar Enko, Medical University of Graz, Austria Iron Status Determination with Conventional and New Biomarkers in Patients with Helicobacter pylori
Infection
P-06 Subhashree Mallika Krishnan, Beaumont Hospital, Westland, MI Prevalence of Helicobacter pylori in Sleeve Gastrectomy (SG) Specimens and a Case Report of Large
Ectopic Pancreas Polyp
P-07 Arizumi Kikuchi, Daiyukai Research Institute for Medical Science, Japan Improving MicroRNA Extraction by Reagent Optimization
P-08 Ahsan Siddiqi, Mayo Clinic, Jacksonville, FL Ossifying Granular Cell Tumor
P-09 Ahsan Siddiqi, Mayo Clinic, Jacksonville, FL Metastatic Thyroid Carcinoma to the Kidneys; Presenting as Bilateral Renal Masses: A Rare Case Report
and Literature Review
Session-III @ Seattle IDigital & Computational| Molecular | Onco | Immuno & Forensic Pathology
Chairs: Timothy C. Thompson, MD Anderson Cancer Centre, Houston, TX Elizabeth Chlipala, Premier Laboratory, LLC, Longmont, CO
09:00-09:20 Timothy C. Thompson, MD Anderson Cancer Centre, Houston, TX PARP Inhibition Suppresses GR MYCN CDK5 RB1 E2F1 Signaling and Neuroendocrine
Differentiation in Castration-Resistant Prostate Cancer
09:20-09:40 Elizabeth Chlipala, Premier Laboratory, LLC, Longmont, CO NSH/DPA Online Digital Pathology Certificate of Completion
09:40-10:00 Hua Xu, The University of Texas Health Science Center, Houston, TX Cancer Information Extraction from Pathology Reports Using Natural Language Processing (NLP)
10:00-10:20 Dana Quesinberry, University of Kentucky, Lexington, KY Impact of a Drug Overdose Decedent Toxicology Testing Legislative Mandate on Informing
Coroner Death Investigation and Certification Practices
10:20-10:40 Coffee Break @ Prefunction Foyer
10:40-11:00 Raju C. Reddy, University of Pittsburgh, Pittsburgh, PA Key Functions and Therapeutic Prospects of Nur77 in Inflammation Related Lung Diseases
11:00-11:20 Rongqin Ren, Ohio State University, Columbus, OH Resolving HER2 Discrepancies in Breast Cancer Using Genomic Profiling
11:20-11:40 Torsten Landwehr, LMU Munich, Germany Sports-related Deaths
11:40-12:00 Joshy George, Jackson Laboratory for Genomic Medicine, Farmington, CT Machine Learning in Biology and Medicine
12:00-12:20 Steven J Soldin, NIH, Bethesda, MD The Role of Mass Spectrometry in Optimizing the Diagnosis and Treatment of Adrenal Disease
12:20 Lunch & Departures @ Dallas/Houston
Med
pat
h-20
20 P
rog
ram
DaY...Three Feb 19Wednesday
Notes: ______________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________
Notes: ______________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________
UNITED Scientific Group
A non-profit organization
We wish to see youat
MedPath-2021Houston, TX
# 8105, Rasor Blvd - Suite #112, PLANO, TX 75024, USAPh: +1-469-854-2280/81; Toll Free: +1-844-395-4102; Fax: +1-469-854-2278
Email: [email protected]: https://medicalpathology.unitedscientificgroup.org/